PERTH-BASED biotechnology player Rockeby Biomed is one step away from receiving a US patent covering the intellectual property of its point-of-care rapid diagnostic test, Candia5.
08/06/2004 - 22:00
Rockeby’s patent
08/06/2004 - 22:00
